Page 2 - Best Burkitt"s lymphoma doctors: TOP 70 doctors

Dr. Michael Shapira specializes in Bone Marrow Transplantation at Sourasky Medical Center (Ichilov), with extensive experience treating blood cancers.

• Graduated from Hebrew University Medical School
• Specialized in internal medicine at Hadassah Medical Center
• Senior physician in Bone Marrow Transplantation at Hadassah

Dr. Dror Levin specializes in pediatric hematology oncology, focusing on Burkitt's lymphoma at Sourasky Medical Center in Tel Aviv.

• Director of children's hematology oncology department at Sourasky Medical Center
• Specialized in pediatric hematology and oncology at Schneider Children's Medical Center
• Member of the Israel Society of Pediatric Hematology Oncology (ISPHO)
• Studied bone and soft tissue oncology at Rizzoli Orthopaedic Institute in Italy

Dr. Fredi Aviv has over 34 years of experience of experience treating blood cancers at Tel Aviv's leading Sourasky Medical Center.

• 34 years of experience dedicated to oncohematology
• Specializes in aggressive blood cancers
• Practices at the renowned Sourasky Medical Center
• Expertise in the latest medical and biological therapies

Pioneering hematologist specializing in Burkitt's lymphoma at Intrarat Hospital – trained at Thammasat University, a leading center for hematology in Thailand.

• Board-certified in hematology with focus on lymphoma cases
• Developed clinical risk prediction model for cancer-associated complications
• Former instructor for nursing students at multiple hospitals
• Active participant in Thailand's hematology academic community

Specialized in Medical Oncology at Akdeniz University – Dr. Alemdar focuses on Burkitt's lymphoma and other hematological cancers.

• Graduated from Kocaeli University Faculty of Medicine in 2006
• Completed specialization in Medical Oncology in 2018
• Worked at Akdeniz University Hospital for several years
• Currently practices at Medical Park Antalya Hospital Complex

Dr. Ayhan Gulsan specializes in Burkitt's lymphoma with advanced training in stem cell transplantation at Duke University and Fred Hutchinson Cancer Research Center.

• Over 25 years of experience of experience in hematology and stem cell transplantation
• Founder and manager of Gazi University's Adult Stem Cell Transplant Unit
• Member of the Turkish Hematology Association
• Published numerous research papers on hematologic malignancies and transplantation outcomes

A leading hematology expert recognized by the American Society of Hematology, Dr. Yair treats patients at Tel Aviv's Sourasky Medical Center.

• Specialized residency in hematology at Tel Aviv Medical Center
• Winner of multiple research grants and awards for clinical excellence
• Active member of both the Israeli and American Hematology Associations
• Focus on leukemia research, including lymphocytic forms

Prof. Wolfgang Köstler is a distinguished Austrian oncologist specializing in targeted cancer therapies, with over two decades of experience.

• Expert in breast cancer and gynecologic malignancies
• Developed personalized treatment strategies using advanced biomarkers
• Associate Professor at the Medical University of Vienna
• Published extensively in leading international oncology journals

Professor Drach specializes in oncology with a focus on Burkitt's lymphoma, offering expert consultations at Confraternitaet Private Hospital.

• Head physician at University Hospital of Internal Medicine I in Vienna
• Director of the Multiple Myeloma and Malignant Lymphoma program
• Member of the Board of Directors of the Austrian Society of Hematology and Oncology
• Published over 120 scientific papers

Dr. Eckhart Weidmann leads the Hematology sector at Nordwest Clinic with over 36 years of experience of practice in treating blood disorders.

• Specializes in non-Hodgkin lymphoma treatment
• Professor with extensive academic and clinical expertise
• Dedicated to treating complex hematological conditions

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.